Related Experiment Video
Updated: Jun 2, 2026
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
The BRCA1 ubiquitin ligase and homologous recombination repair
Tomohiko Ohta1, Ko Sato, Wenwen Wu
1Department of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki 216-8511, Japan. to@marianna-u.ac.jp
Abstract:
Impairment of homologous recombination (HR), a vital process employed during repair of DNA double strand breaks and stalled DNA replication, provides a valuable opportunity for the cell to become transformed. Once transformed, the impairment turns to be a target for therapy as exemplified by the synthetic lethal strategy such as poly (ADP-ribose) polymerase (PARP) inhibitor for BRCA1/2-defective breast and ovarian cancer. Hence, improving mechanistic understanding of HR has emerged as an urgent issue to address due to the high clinical demand. Ubiquitin modification plays a central role in HR and more than a few E3 ubiquitin ligases have been implicated in the process. However, the significance of the activity of one such key E3 ligase, BRCA1, has not yet been clarified and remains as a major obstacle in the field. Here, we review recent advances in our understanding of BRCA1 function in HR and discuss possible roles of the activity.
Insights
Understanding BRCA1
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Homologous recombination (HR) is crucial for DNA repair and replication.
- Impaired HR can lead to cancer and is a target for synthetic lethal therapies, like PARP inhibitors for BRCA1/2-defective cancers.
- BRCA1 is a key E3 ubiquitin ligase involved in HR, but its precise role remains unclear.
Purpose of the Study:
- To review recent advances in understanding BRCA1's function in homologous recombination.
- To discuss the potential roles of BRCA1 activity in HR.
Main Methods:
- Literature review of recent research on BRCA1 and HR.
- Analysis of existing data on E3 ubiquitin ligases and DNA repair pathways.
Main Results:
- BRCA1's role in HR is complex and multifaceted.
- Ubiquitin modification by BRCA1 influences HR efficiency and fidelity.
Conclusions:
- Further elucidation of BRCA1's E3 ligase activity is critical for understanding HR.
- Targeting BRCA1-mediated pathways may offer new therapeutic strategies for cancers with defective HR.
Related Concept Videos
02:31Homologous Recombination
02:31Homologous Recombination
01:08Nucleotide Excision Repair
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
02:04Fixing Double-strand Breaks